Adamis Pharmaceuticals Corp (ADMP)

[Seventeenseconds]

According to CRT Capital, Adamis, with their recently raised $10.6 Million Cash, Adamis has sufficient cash to launch its epinephrine pre-filled syringe (for the treatment of anaphylaxis) and continue to develop its respiratory treatment pipeline, which includes APC-5000, APC-1000 (HFA beclomethasone comparable to Teva's QVAR), and APC-3000. IN MY OPINION, we are just about to embark on a period of indestructibility, with a continuation and acceleration to $70. Adamis has the cash to develop its products in a market worth 10's of billions of dollars. With a market cap of less than 100M, this is an easy 10 bagger, $70 PPS, and that doesn't even get us to a respectable 1B market cap.